This article was originally published in The Gray Sheet
Firm's Premier type-specific HSV-1 and HSV-2 IgG enzyme-linked immunosorbant assay (ELISA) herpes tests gain FDA clearance. The two tests are the first cleared by the agency "proven to be able to distinguish" between oral herpes simplex virus (Type 1) and genital herpes simplex virus (Type 2) via serological blood test methods, Meridian claims. About 200,000-500,000 people contract herpes annually; as many as 30 mil. Americans are infected with HSV-2
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.